These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15228165)

  • 1. Detection times of drugs of abuse in blood, urine, and oral fluid.
    Verstraete AG
    Ther Drug Monit; 2004 Apr; 26(2):200-5. PubMed ID: 15228165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of rohypnol.
    Samyn N; De Boeck G; Cirimele V; Verstraete A; Kintz P
    J Anal Toxicol; 2002; 26(4):211-5. PubMed ID: 12054361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
    Samyn N; De Boeck G; Verstraete AG
    J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of oral fluid tests for drugs of abuse.
    Cone EJ; Huestis MA
    Ann N Y Acad Sci; 2007 Mar; 1098():51-103. PubMed ID: 17332074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
    Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
    J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids.
    Christodoulides N; De La Garza R; Simmons GW; McRae MP; Wong J; Newton TF; Smith R; Mahoney JJ; Hohenstein J; Gomez S; Floriano PN; Talavera H; Sloan DJ; Moody DE; Andrenyak DM; Kosten TR; Haque A; McDevitt JT
    Drug Alcohol Depend; 2015 Aug; 153():306-13. PubMed ID: 26048639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Workplace drug testing, different matrices different objectives.
    Tsanaclis LM; Wicks JF; Chasin AA
    Drug Test Anal; 2012 Feb; 4(2):83-8. PubMed ID: 22362574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of drugs of abuse in Cerumen - correlation of postmortem analysis results with those for blood, urine and hair.
    Meier SI; Koelzer SC; Schubert-Zsilavecz M; Toennes SW
    Drug Test Anal; 2017 Oct; 9(10):1572-1585. PubMed ID: 28240418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Drugs in Simultaneously Collected Samples of Oral Fluid and Blood.
    Bakke E; Høiseth G; Arnestad M; Gjerde H
    J Anal Toxicol; 2019 Apr; 43(3):228-232. PubMed ID: 30295809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for drugs of abuse in oral fluid--correlation of analysis results with serum in forensic cases.
    Toennes SW; Steinmeyer S; Maurer HJ; Moeller MR; Kauert GF
    J Anal Toxicol; 2005; 29(1):22-7. PubMed ID: 15808009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake.
    Nordal K; Øiestad EL; Enger A; Christophersen AS; Vindenes V
    Ther Drug Monit; 2015 Aug; 37(4):451-60. PubMed ID: 25549207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of drug concentrations between whole blood and oral fluid.
    Langel K; Gjerde H; Favretto D; Lillsunde P; Øiestad EL; Ferrara SD; Verstraete AG
    Drug Test Anal; 2014 May; 6(5):461-71. PubMed ID: 24039237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
    West R; Mikel C; Hofilena D; Guevara M
    Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substance abuse detection in substitution therapy : Oral fluid versus urine screening].
    Stein J; Geraedts M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1261-1268. PubMed ID: 28929198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for drugs of abuse in saliva and sweat.
    Kidwell DA; Holland JC; Athanaselis S
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):111-35. PubMed ID: 9700555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Urine and Oral Fluid for Workplace Drug Testing.
    Casolin A
    J Anal Toxicol; 2016 Sep; 40(7):479-85. PubMed ID: 27344042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes.
    Ventura M; Pichini S; Ventura R; Leal S; Zuccaro P; Pacifici R; de la Torre R
    Ther Drug Monit; 2009 Apr; 31(2):277-80. PubMed ID: 19307939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.